Residual persistence of cytotoxicity lymphocytes and regulatory T cells in patients with severe coronavirus disease 2019 over a 1‐year recovery process

AIM: To clarify the immune cellular changes in critically ill patients recovering from coronavirus disease 2019 (COVID‐19). METHODS: The immune response of peripheral blood mononuclear cells from patients with severe COVID‐19 in different stages of recovery (3, 6, and 12 months from hospitalization)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuyama, Yumi, Yamakawa, Kazuma, Kayano, Katsuhide, Maruyama, Miho, Umemura, Yutaka, Wada, Takeshi, Fujimi, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597380/
https://www.ncbi.nlm.nih.gov/pubmed/36311179
http://dx.doi.org/10.1002/ams2.803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597380/
https://www.ncbi.nlm.nih.gov/pubmed/36311179
http://dx.doi.org/10.1002/ams2.803

Ejemplares similares